RESPIRATORY SYNCYTIAL VIRUS RNA VACCINE

The present disclosure provides a respiratory syncytial virus (RSV) vaccine comprising a messenger RNA (mRNA) comprising an open reading frame (ORF) encoding an RSV F protein antigen, and methods of eliciting an immune response by administering said vaccine. La presente divulgación proporciona una v...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOLDMAN Rebecca L, DINAPOLI Joshua, ZHANG Linong, PARRINGTON Mark, GALLICHAN William Scott, GOPANI Hardip Rajeshbhai, CHIVUKULA Sudha, CASIMIRO Danilo
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides a respiratory syncytial virus (RSV) vaccine comprising a messenger RNA (mRNA) comprising an open reading frame (ORF) encoding an RSV F protein antigen, and methods of eliciting an immune response by administering said vaccine. La presente divulgación proporciona una vacuna contra el virus respiratorio sincitial (VRS) que comprende un ARN mensajero (ARNm) que comprende un marco de lectura abierto (ORF) que codifica un antígeno proteico F del VRS, y métodos para provocar una respuesta inmunitaria mediante la administración de dicha vacuna.